Speakers

Speakers' Biographical Sketches

	Aleksandra Ristic-Fira Aleksandra Ristic-Fira is Research Professor and Head of the Radiation Biology Division, at the Laboratory of Molecular Biology and Endocrinology of the Vinca Institute of Nuclear Sciences, University of Belgrade. During postdoctoral studies at Unite de Virologie - fondamentale et appliquee, INSERM, CNRS, in Lyon, France and at Cornell University, Department of Poultry and Avian Sciences, Ithaca, New York, USA, her research field was molecular biology of malignant cells and immunology. Starting from 1998 she was principal researcher and spokesperson in international collaboration projects with University of Glasgow, Scotland UK, Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali del Sud, Italy and Centre d'Etudes Nucleaires de Bordeaux-Gradignan (CENBG) CNRS/IN2P3/Universite Bordeaux 1 and member of research teams engaged in FP7 and Horizon2020 actions. Within GEANT4 Collaboration at CERN, she is member of the Low Energy and Advanced Examples Working Groups involved in the biological validation of models. Member of the ELIMED project team aimed to the clinical applicability of the laser-driven proton beams in the hadrontherapy field which is in collaboration with the ELI-Beamlines (Prague, Czech Republic). She was foreign reviewer of INFN projects in the field of radiobiology and external reporter of PhD thesis at PMF, University of Montenegro. Presently, she is professor on postgraduate studies at the University of Belgrade in the field of radiation biology of the cell and biomedicine.
	Cristina Tintori Cristina Tintori obtained a degree with laude in Chemistry and Pharmaceutical Technologies at University of Pisa in 2002 and, in October 2007 she got the PhD in Pharmaceutical Sciences at the University of Siena. Since 2008 she is a research associate at the Department of Biotechnology, Chemistry and Pharmacy of the University of Siena. Dr. Cristina Tintori scientific activity is mainly focused on medicinal chemistry topics and in particular to the design of new anticancer and antiviral compounds by the application of molecular modeling techniques. The scientific interests of Cristina Tintori in computational chemistry encompass ligand-based and structure-based drug design methods such as QSAR, 3D-QSAR, pharmacophore modeling, docking studies, molecular dynamics and free energy perturbation calculations. Cristina Tintori has published more than 40 articles on peer-reviewed international journals. She is administrative board member of Lead Discovery Siena Srl, a spin-off of University of Siena which operates in the field of drug discovery.
	Giacomo Cuttone Director of INFN-Laboratori Nazionali del Sud (LNS) until july 31th 2019. He is working since 1985 at INFN-LNS in accelerator physics. Member of the Superconducting Cyclotron Project leading the computer control system and extraction system, responsible of the accelerator operation and deputy of the LNS Accelerator Division. Member of the EXCYT project for the development of the radioactive ion beam facility at LNS. Since 2002 he worked as a project leader. Also a leader of the first Italian proton therapy facility (CATANA) realized at LNS and in operation since 2002. Until now 350 patients affected by eye tumor has been successfully treated. Prof. Cuttone is a developer of new detectors for application in medical physics in collaboration with Italian and foreign academic institutions. Member of the OCSE panel for definition of the roadmap in nuclear physic and member of the Eurisol site committee. Italian representative for H2020-Euratom at Bruxelles. President of the INFN National Scientific Committee for the technological and Interdisciplinary for three years (2008-2011)
	Ivan Petrovic Research Professor in the Laboratory of Physics at the VINCA Institute of Nuclear Sciences, University of Belgrade. He graduated from and obtained the Master of Sciences degree at the Faculty of Electrotechnical Engineering of the University of Belgrade in the field of nuclear reactor physics. He got PhD degree at Departement de Physique des Reacteurs Nucleaires, Universite de Paris XI (Sud) - Orsay (France). For seven years he worked at Centre d'Etudes Nucleaires de Saclay, Commissariat a l'Energie Atomique (France), Ecole Polytechnique de Montreal (Canada) and University of California at Berkeley (USA). At the VINCA Institute of Nuclear Sciences his activities are aimed to experimental radiation biology and medical physics. He collaborated with Ludwig-Maximilians-Universitat Munchen - Garching (Germany) and Paul Scherrer Institut (PSI) - Villigen (Switzerland). He was Assistant Minister in the Ministry of Science, Technology and Development of the Government of the Republic of Serbia, where he was Head of Department of Basic Research. For years he is Guest Researcher at Laboratori Nazionali del Sud (LNS) of Istituto Nazionale di Fisica Nucleare (INFN) (Italy). Within GEANT4 Collaboration at CERN, he participates in Low Energy, Advanced Examples and GEANT4-DNA Working Groups. He was external reviewer of research projects financed by INFN and Head of the bilateral project with Centre d'Etudes Nucleaires de Bordeaux-Gradignan (CENBG) CNRS/IN2P3/Universite Bordeaux 1 (France). He is Group Leader within the projects ENSAR (European Nuclear Science and Applications Research) and ENSAR2, Transnational Access Activities and Networking Activities, of the European Commission, and participates in ELIMED project of ELI-Beamlines (Czech Republic).
	Nevena Veljkovic Head of the Centre for Multidisciplinary Research of the Vinca Institute of Nuclear Sciences, University of Belgrade. In 2001, she received her PhD in Chemistry and Technology from the University of Belgrade. Her main activities encompass biomolecular medicine projects and her research interests include predictions of protein interactions, protein function annotation and the study of protein domains and their associations with disease. Dr. Veljkovic had steered the development of several tools aimed at predicting various protein features, including protein-protein interactions and interpretation of genetic variants associated with the hematologic malignancies. The research interests of dr Veljkovic in computational chemistry include ligand-based computational screening. Dr Veljkovic has teaching duties for the PhD program at the Faculty of Pharmacy. She has published more than 40 articles on peer-reviewed international journals.
	Pablo Cirrone Expert of the use of proton and ion in radiation treatment and of absolute and relative dosimetry in electron, photon and ion beam. He got his PhD title in 2003 discussing a thesis on the use of the Monte Carlo Geant4 code in hadrontherapy applications. He is expert of the development and test of detectors for medical applications and expert of the development and use of Monte Carlo-based techniques for the simulation of problems related to the medical physics and nuclear fields. Since 2002 he belongs to the Geant4 Collaboration being responsible for the development and maintenance of an example for the simulation of iontherapy related problems. Also a member of the Geant4 Steering Board as responsible of the "Advanced Examples" working group. Responsible of the protontherapy beam line and of the interdisciplinary beam-line at the Laboratori Nazionali del Sud of INFN coordinating and supporting various experimental Groups. National Responsible of the ELIMED project. ELIMED aims to demonstrate the clinical applicability of the laser-driven proton beams in the hadrontherapy field. The project started in collaboration with the ELI-Beamlines Researchers (Prague, CZ) where one of the most powerful laser will be realized within 2017. Is scientific coordinator for the realization of the ELIMED beamline at ELI-Beamlines where the first open-to-users multidisciplinary beamline for laser- driven beams will be realized within 2017.
	Paolo De Paoli Paolo De Paoli is the Scientific Director of the Centro di Riferimento Oncologico (CRO) of Aviano - National Cancer Institute, Italy. He has graduated in Medicine in Padua (Italy) University. He was the Director of the Division of Microbiology-Immunology-Virology for over 20 years and is a true expert in cancer-related viruses and infectious agents. He acted as referee in cancer research for the European Commission. He received grants in the Framework Programs V and IV of the European Commission on viruses and cancer. His main research interests are immunological and virological aspects related to oncology. He has published more than 300 scientific papers.
	Pavle Zelic International Cooperation and Public Relations Manager, Office of Managing Director at Medicines and Medical Devices Agency of Serbia. Responsible for International cooperation, Management of international projects, cooperation with regulatory bodies in other countries and international organizations, presentation of Medicines and Medical Devices Agency of Serbia on national and international expert meetings. Person responsible for relation with media (press releases, answers to media, press conferences), organization of expert meetings, website and Intranet site management, Internal communication management, production and management of production of promotional materials for Medicines and Medical Devices Agency of Serbia.